# OnCo record paper-monarche-lancet-oncol-2023 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-monarche-lancet-oncol-2023/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-monarche-lancet-oncol-2023" ;
  schema:name "Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial"@en ;
  schema:description "Published report from the monarchE trial registered as NCT03155997, in The Lancet Oncology (2023), chosen as the most cited paper whose own text cites the registry id."@en ;
  schema:url <https://onco.cc/key-papers/paper-monarche-lancet-oncol-2023/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/s1470-2045(22)00694-5>, <https://pubmed.ncbi.nlm.nih.gov/36493792/>, <https://europepmc.org/article/MED/36493792>, <https://clinicaltrials.gov/study/NCT03155997> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1016/s1470-2045(22)00694-5> ;
  schema:datePublished "2023"^^xsd:gYear ;
  schema:author "Johnston SRD, Toi M, O'Shaughnessy J, et al." ;
  onco:trials <https://onco.cc/trials/monarche/> ;
  onco:journals <https://onco.cc/journals/lancet-oncology/> .